Our Services

Market Access and Pricing Strategies

We develop pan-European market access strategies encompassing pricing and reimbursement, HTA, NHS business cases, stakeholder engagement plans (regional/local payers, patient groups policymakers).

HTA Strategy and Managing Submissions

We have extensive experience with HTA submissions across various therapy areas (e.g., (immuno) oncology, immunology/dermatology, hematologic malignancies, CNS, and orphan diseases), including NICE, SMC, AWMSG, G-BA, HAS, TLV, NOMA submissions.

Payer Value Proposition Development

We are experts in creating payer product value propositions for early and late-stage development with extensive HEOR and market access input into clinical trial program to support European reimbursement

Strategic HTA and Market Access Project Leadership

We are adept at working within matrix organizations to build coalitions of senior management in support of complex projects, while delivering on-time results

Real World Evidence Generation

Expertise in designing, implementing, evaluating, and utilizing real-world/outcomes data for pre-launch, HTA support, post-marketing/reimbursement commitments.